Drug-induced Diseases: Prevention, Detection, and Management

Front Cover
ASHP, 2010 - Medical - 1110 pages
1 Review
According to the authors, a drug-induced disease as an unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. Since the first edition of this book was published in 2005, numerous drugs have been withdrawn from the market in the United States as a result of morbidity and/or mortality associated with drug-induced diseases. Despite best efforts to assure that all drugs are safe and effective, millions of patients each year develop drug-induced diseases. Every time a patient presents with a new disease or an exacerbation of an existing condition, someone needs to ask, “Could this be drug-related?”Now in its second edition, this popular and essential comprehensive resource provides a detailed analysis of how to identify, prevent, and manage drug-induced diseases. Edited by James E. Tisdale and Douglas A. Miller, with contributions from experts distinguished in their respective specialties, Drug-Induced Diseases is organized logically and is easy to use for pharmacists, physicians, nurses, and pharmacy students alike.Inside you'll find:
  • Chapters dedicated to each disease state.
  • In-depth tables throughout each chapter.
  • A new section on Drug-Induced dermatologic diseases.
  • New drugs implicated as the cause of specific disease(s).
  • The inclusion of the Levels of Evidence classification scheme for identifying drug-induced diseases.
  • And much more.
  

What people are saying - Write a review

Great Transaction

User Review  - pharmdude - Overstock.com

The book came exactly as advertized, and delivery was prompt. What more would anyone want? Read full review

Contents

CONTENTS CONTENTS
5
CHAPTER
11
Evaluating Patients for DrugInduced Diseases
40
DrugInduced Dermatologic Diseases
49
CHAPTER
54
Impact
98
CHAPTER 8
131
Postmarketing Surveillance for DrugInduced DrugInduced Neurological Diseases
151
CHAPTER 29
554
SECTION VII
569
CHAPTER 31
586
Hypothalamic Pituitary and Adrenal
605
CHAPTER 33
629
CHAPTER 34
644
CHAPTER 35
681
CHAPTER 36
702

Hugh H Tilson Seizures
179
Stroke
190
CHAPTER 12
205
CHAPTER 13
236
CHAPTER 32
245
CHAPTER 14
250
CHAPTER 15
275
CHAPTER 16
293
SECTION IV
315
CHAPTER 19
333
SECTION V
357
SECTION VI
399
CHAPTER 24
419
CHAPTER 25
445
CHAPTER 26
485
CHAPTER 27
516
CHAPTER 28
529
SECTION VIII
727
CHAPTER 38
738
JaneM Gervasio
760
JaneM Gervasio
771
CHAPTER 41
800
Nausea Vomiting and Anorexia
819
Acute Kidney Injury
853
Syndrome of Inappropriate Antidiuretic Hormone
885
CHAPTER 46
903
SECTION X
927
819
941
Anemias
973
Ototoxicity
1049
Index
1065
941
1068
Copyright

Common terms and phrases

About the author (2010)

James E. Tisdale, PharmD, BCPS, FCCP   Dr. Tisdale received his B.Sc. Pharm from the University of Manitoba in 1983 and his Pharm.D. from S.U.N.Y. at Buffalo in 1988. He completed a pharmacy practice residency at the University of Manitoba Health Science Center in 1984 and a Fellowship in Cardiovascular Therapeutics at Hartford Hospital (CT.) from 1988-1990. He is currently Professor of Pharmacy Practice in the Department of Pharmacy Practice Personnel at the Purdue University School of Pharmacy and Pharmaceutical Sciences in Indianapolis, Indiana.   Dr. Tisdale's research interests are in the area of cardiovascular pharmacotherapy, focusing on: mechanisms, risk factors, and management of drug-induced arrhythmias, and drug therapy for prevention and treatment of atrial fibrillation. His research has resulted in the publication of nearly 50 journal articles, 6 book chapters and 40 research abstracts in addition to his co-editorship of Drug-Induced Diseases. Prevention, Detection and Management.   Dr. Tisdale's research has been funded by the American Heart Association, numerous foundations, and the pharmaceutical industry. From 2001-2004, he was a member of the Board of Regents of the American College of Clinical Pharmacy, and from 2008-2009 he was Chair, Clinical Sciences Section, Academy of Pharmaceutical Research and Science, American Pharmacists Association (APhA). Dr. Tisdale is currently President-Elect of the American College of Clinical Pharmacy (ACCP).     Douglas A. Miller, Pharm.D.   Dr. Miller is a professor at the Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences in Detroit, where he teaches courses dealing with professional practice and patient care. He earned his BS in Pharmacy from The Ohio State University College of Pharmacy and his Pharm.D. from the Philadelphia College of Pharmacy and Science. His pharmacy experience includes practice in community, long term care and hospital settings. For more than 20 years, he led a team that conceptualized and implemented innovative clinical pharmacy services at Detroit's Henry Ford Hospital.   Dr. Miller served as a member of the Michigan Board of Pharmacy for 11 years including two terms as board chair. He has also served as a member of the Board of Trustees of the American Pharmacists Association and the boards of both the Michigan Pharmacists Association and the Michigan Society of Health-System Pharmacists. He is the recipient of several awards and honors including the Annual Alumni Award of the University of the Sciences in Philadelphia and the Distinguished Alumni Award of the Ohio State University College of Pharmacy, the Pharmacist of the Year Award of the Michigan Pharmacists Association, and awards from both ASHP and APhA for outstanding practice in hospital pharmacy. In 1990, 1991, 1995, 2004, and 2007 he was named "Teacher of the Year" at the Wayne State University Applebaum College of Pharmacy and Health Sciences. Dr. Miller is a Fellow of the American Pharmacists Association.

Bibliographic information